Prostate cancer — all decisions

The Board remands the claim for compensation under 38 U.S.C. § 1151 for prostate cancer due to a pre-decisional error in the duty to assist, specifically the need for an opinion that addresses the Veteran's family history of prostate cancer.

The Board granted service connection for prostate cancer residuals, Parkinson's disease, ischemic heart disease, hypothyroidism, peripheral neuropathy, and testicular disability on a basis other than the PACT Act.

The Board remands the claims for service connection for multiple myeloma, prostate cancer, and chronic kidney disease due to a need for additional development of evidence regarding exposure to toxic substances during service.

The Board granted service connection for prostate cancer, effective from the date of enactment of the PACT Act. The appeal for tuberculosis was remanded.

The Board denied service connection for prostate cancer as there was no evidence of in-service herbicide exposure and the condition did not manifest within one year of service or otherwise relate to service.

The Board denied service connection for prostate cancer, and remanded claims for a psychiatric disability, memory loss disorder, tinnitus, and peripheral vestibular disorder with vertigo.

The Board dismissed the appeal for entitlement to service connection for prostate cancer and TDIU as there are no further allegations of error of fact or law for appellate consideration.

The Board denied service connection for sinusitis and remanded claims related to earlier effective dates, peripheral neuropathy, and ED.

The Board granted a compensable initial evaluation for prostate cancer residuals and an acquired psychiatric disorder, but denied increased ratings for tinnitus, TBI, and other conditions. Effective dates were also granted for the grant of service connection for certain disabilities.

The Veteran withdrew the appeal for service connection of prostate cancer, and the claim was dismissed.

The Board denied the Veteran's claims for increased ratings and reinstatement of a 100 percent rating for prostate cancer, but granted a 40 percent rating from November 12, 2019, for voiding dysfunction as a residual of prostate cancer.

The appeal for bilateral hearing loss was dismissed, while service connection for prostate cancer due to herbicide exposure was granted.

The Board denied service connection for various conditions, including prostate cancer, diabetes mellitus, tremors (claimed as Parkinson's disease), erectile dysfunction, an acquired psychiatric disorder, diabetic retinopathy, hypertension, and peripheral neuropathy and vascular disease in the extremities.

The Board remands the issues of service connection for renal cell cancer, prostate cancer, and hepatitis to request additional development under 38 C.F.R. § 3.311.

The Board remands the matter for a VA Housebound and Aid and Attendance examination to determine if the Veteran's service-connected PTSD with TBI renders him permanently housebound.

The Board granted service connection for prostate cancer and DMII based on the Veteran's exposure to herbicide agents while stationed at Takhli Royal Thai Air Force Base.

The Board denied service connection for prostate cancer but granted a 70% rating for bipolar disorder and a TDIU effective January 9, 2017.

The Board denied service connection for prostate cancer, hypertension, diabetes mellitus, and sleep apnea as these conditions were not etiologically related to the Veteran's service, including exposure to ionizing radiation and TCE.

The Board granted service connection for diabetes, coronary artery disease and old myocardial infarction, prostate cancer, left lower extremity diabetic neuropathy, right lower extremity diabetic neuropathy, erectile dysfunction, and special monthly compensation based on loss of use of a creative organ. The claims for service connection for a left leg skin disorder, vision disorder, and obstructive sleep apnea were denied.

The Board remands the claim for service connection of prostate cancer to obtain a medical opinion in compliance with the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxins Act of 2022 (PACT Act).